Biopsy Forceps Market Outlook (2022 to 2027)
The global biopsy forceps market is set to enjoy a valuation of US$ 260.8 million in 2022, and further expand at a CAGR of 4% to reach US$ 317.3 million by the year 2027.
Sales of cupped jaws are expected to expand at a CAGR of 4.7% from 2022 to 2027 and reach a valuation of US$ 118 million by 2027.
| Report Attributes |
Details |
| Biopsy Forceps Market Size (2022E) |
US$ 260.8 million |
| Forecasted Market Value (2027F) |
US$ 317.3 million |
| Global Market Growth Rate (2022 to 2027) |
4% CAGR |
| China Market Growth Rate (2022 to 2027) |
6% CAGR |
| Key Companies Profiled |
Olympus Corporation; Boston Scientific Corporation; Medi-Globe GmbH; Scanlan International; Medline Industries, Inc.; Omnimed Ltd.; Cook Medical; Cardinal Health; STERIS Corporation; Medgyn Products, Inc.; Micro-Tech Endoscopy; Key Surgical GmbH; Jiangsu Ate Medical Technology Co., Ltd. |
Global Demand for Biopsy Forceps (2017 to 2021) Vs. Market Predictions (2022 to 2027)
Biopsy forceps are surgical tools used by surgeons and other medical professionals to grasp or hold things/objects and collect samples, particularly tissues, for the testing and diagnosis of diseases.
Health care professionals can choose the best course of treatment after analysing the disease status of a sample taken using biopsy forceps from a patient's body.
Also, during surgical treatment, these biopsy forceps are employed by surgeons to handle tissues and crucial organs to carry out safe surgery.
Market participants offer a variety of sizes and styles of biopsy forceps, including straight, angled, short, and long. The kind of biopsy forceps to be used depends on the technique to be carried out, such as tissue samples or surgical procedures such as gynaecological procedures.
Based on application, various types of forceps are available on the market, such as endoscopy forceps, endometrial biopsy forceps, laparoscopic biopsy forceps, bronchoscopy biopsy forceps, capsulorhexis forceps, and cervical punch biopsy forceps. Tischler biopsy forceps also known as punch biopsy forceps is a non-ratcheted, double spring OB/GYN instrument most commonly used during colposcopy procedures to collect cervical tissue samples for biopsy.
Although the basic concept of biopsy forceps has not changed significantly, a variety of biopsy forceps with different materials and designs are in use. A growing emphasis on enhancing endoscopic research and development skills, supported by regulatory clearances and launches from key players, has resulted in novel advancements in the market.
Furthermore, manufacturers have begun to invest in the medical device industry as a result of the surge in healthcare spending and funding linked to favourable reimbursement. As a result, the demand for disposable biopsy forceps will rise in popularity in the coming years.
One of the key factors anticipated accelerating growth and demand for biopsy forceps is the rise in chronic illnesses such as cancer and gastrointestinal infections including helicobacter pylori (H Pylori). Furthermore, it is also anticipated that an increase in the number of patients undergoing surgical operations and an increase in the need for biopsy forceps for tissue sampling would both contribute to the expansion of the global biopsy forceps market from 2022 to 2027.
Progressing at a CAGR of 4%, the global biopsy forceps market is projected to reach US$ 317.3 million by 2027, reveals Fact.MR, a market research and competitive intelligence provider.
What is Majorly Raising the Sales of Biopsy Forceps?
“Rising Cases of Cancer & Gastrointestinal Illnesses”
- As a result of population increase and ageing, the International Agency for Research on Cancer (IARC) predicts that by 2040, there will be 16.3 million cancer deaths worldwide and 27.5 million new cases of cancer.
- The World Health Organization (WHO) predicts that people 60 years of age and older will increase from 900 million in 2015 to 2 billion in 2050. Age-related medical issues such as medical cancer and gastrointestinal illnesses are more prevalent due to the growing senior population. This is anticipated to drive demand for biopsy forceps to rise globally.
Rapid adoption of minimally-invasive surgical techniques by patients and healthcare professionals as well as the availability of novel and cutting-edge biopsy forceps is predicted to support market expansion. Also, one of the key elements anticipated to propel sales of biopsy forceps is the rise in healthcare spending and population.
What Could Dampen the Demand for Biopsy Forceps to Some Extent?
“Strict FDA Rules & High Production Cost”
The FDA's rigorous regulations and high cost of advanced biopsy tools are anticipated to restrain sales of the biopsy forceps, while a shortage of qualified specialists could pose a problem for market expansion.
Also, the market's sales growth is anticipated to be hampered by the high cost of disposable biopsy forceps.
For instance,
- According to a survey by the Dijon University Hospital, the price of a biopsy session using reusable forceps for the stomach was almost equal to €7.5 (plus €1.92 for sterilization costs), and €8.7 for reusable colonic forceps (with the same sterilization cost). Reusable biopsy forceps are therefore much more beneficial than disposable biopsy forceps from a strictly cost standpoint.
Which Regions Account for High Sales of Biopsy Forceps?
“North America & Europe Lead Market Share Due to Availability of Technologically-Advanced Biopsy Forceps & High Number of Surgical Procedures”
Due to the increasing demand and consumption of biopsy forceps, as a result of several surgical procedures carried out annually in the United States and Canada, North America is predicted to dominate the worldwide biopsy forceps market.
Due to the region's high acceptance rate for technologically advanced products, rising product affordability, and high spending on healthcare services, Europe is anticipated to occupy the second-largest share of the worldwide biopsy forceps market.
During the projected period, the market for biopsy forceps in the Asia Pacific is predicted to expand more rapidly than in other regions. This is due to an increase in the incidence of chronic diseases, such as cancer, in the region, which would likely result in a large patient population undergoing surgical operations and an increase in the use of biopsy forceps.
Country-wise Analysis
What is Pushing the Sales of Biopsy Forceps in the U.S.?
“Rising Rate of Chronic Disorders among Senior Population”
The market for biopsy forceps in North America is dominated by the United States, and it is rising steadily as a result of the growing elderly population in the country.
- According to the U.S. Census Bureau, in the United States, the number of people 65 years of age and older is expected to almost double by 2050 to 83.7 million, from an estimated 43.1 million in 2012. This rise in the elderly population is primarily attributable to the baby boomers. The last of the baby boomers will be above the age of 85 by 2050.
There are certain physical and mental health issues that senior people must be aware of. Ageing is a biological process that develops over time as a result of cellular and molecular damage. Because they are more susceptible to chronic illnesses, the older population is likely to contribute to the expansion of various diagnostic techniques.
Why are Sales of Biopsy Forceps High in China?
“Lung Cancer Prevalence Surging in China”
Sales of biopsy forceps in China are expected to expand at a CAGR of 6% from 2022 to 2027 and reach a valuation of US$ 62 million by 2027.
When it comes to both the rate of newly diagnosed cases and fatalities, lung cancer is the most common malignant tumor in China. Early detection and treatment are important for increasing the survival rate of individuals with lung cancer.
Chest CT scans help find more lung tumors if any are present inside a patient's lungs. The gold standard test or a pathological examination ultimately confirms the final diagnosis. Therefore, there is an urgent need in medical practice for a unique method of safe, accurate, whole-lung diagnosis and therapy.
For instance,
- China finished the first trans-bronchial lung nodule biopsy performed domestically with robotic assistance in March 2022. Market growth for robotic biopsy instruments in China is anticipated to be boosted by similar advances.
Category-wise Analysis
Why are Sales of Disposable Biopsy Forceps Expected to Rise Fast?
“Rapidly Rising Number of Endoscopy Procedures”
Endoscopic applications have grown in popularity as a result of ongoing advancements in endoscopic processing technology. As a result, demand for disposable biopsy forceps is predicted to give profitable potential due to increasing demand for diagnosis and endoscopic treatment.
To encourage the use of minimally-invasive procedures, ongoing funding for the development of sophisticated endoscopic instruments is planned by various market players.
Players in the biopsy forceps market are being encouraged to boost their investments by the strict restrictions put in place to ensure patient safety and hygiene. Companies are also extending their product lines to obtain a competitive edge.
Demand for disposable biopsy forceps will expand overall with the help of new product releases made by market participants using cutting-edge technologies.
Competitive Landscape
Due to low entry barriers, the market for biopsy forceps is extremely fragmented on a global scale. Due to fierce rivalry in the biopsy forceps market, manufacturers are concentrating their investments in emerging regional markets.
Leading companies in the worldwide biopsy forceps market work hard to produce biopsy forceps that are safer and more useful for surgeons and other medical professionals.
For Instance,
- To improve its surgical endoscopy capabilities, Olympus Corporation agreed to purchase Quest Photonic Devices B.V. in January 2021.
